Breakthrough Rice Bran Nanoparticles Show Promise as Affordable and Targeted Anticancer Agent
Researchers discover that nanoparticles derived from rice bran are both effective and safe for the treatment of cancer Several types...
Treatment
Advances In Cancer Treatments
Introduction This article delves into the most advanced and effective cancer treatment options currently available. It provides an in-depth analysis...
MHRA Grants ADvantage Therapeutics Innovative Licensing and Access Pathway (ILAP) Designation for Novel Lead Product AD04™ for Phase 2b Trial in Alzheimer’s Disease
ILAP Designation accelerates patient access and commercialization MIAMI, APRIL 5, 2023 (GLOBE NEWSWIRE) – ADvantage Therapeutics, Inc. (“ADvantage” or “the...
Novel Target-Specific Nanoparticles for Diagnosis and Treatment of Pancreatic Cancer
By Dr. Jill Smith Pancreatic cancer is well known as one of the deadliest cancers, with a paltry 11% survival...
Natural VS Safe Ingredients: What Matters When it Comes to Our Beauty Products?
By Michael Ambacher We all want to look and feel our best – but finding the right products to support...
Treating Alzheimer’s: Is It Really an Autoimmune Disease?
Although Alzheimer’s is still listed as an incurable neurodegenerative disease, medical science has come a long way in terms of...
Dysphagia From a Medical Standpoint
Dysphagia is an umbrella term which doctors use to describe difficulty swallowing. This is not the same as pain whilst...
CureVac Expands Lead RNA Cancer Program Phase 1 Trial in Advanced Melanoma
CV8102 recommended dose identified; expansion trial to confirm safety, tolerability, and efficacy Trial expansion focuses on advanced melanoma, an indication of...
Innovative Product ExoFlo™ Fulfills Unmet but Urgent Medical Need in COVID-19 Treatment
Medical professionals report dramatic and consistent success in treating patients gravely ill with COVID-19-associated Acute Respiratory Distress Syndrome (ARDS) Treatment...
Pharnext and the University Hospital Institute Méditerranée Infection Announce a Joint Effort to Evaluate Repurposed Drugs for Potential Use Against the COVID-19 Virus
Rapid in vitro testing of repurposed drug candidates identified by Pharnext's PLEOTHERAPYTM Artificial Intelligence platformPARIS, France, 8:00am, April 22, 2020 (CET) - Pharnext SA...
Immunomedics In Software Project With Ideagen To Streamline Document Reviews Of Cancer Treatment Processes
Ideagen’s PleaseReview will improve review, co-authoring and redaction projects linked to cancer and other oncology treatments US-based pharmaceutical company, Immunomedics, is...
How Public Health Informatics Can Be Used to Treat Drug Addiction
Researchers use big data analytics to find opportunities to help alleviate drug addiction amid the U.S. opioid crisis. Since 2004,...
